Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202551019 | Benzocaine + trimethobenzamide hydrochlor 2%ww/200mg (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215454010 | Benzocaine + trimethobenzamide hydrochlor 2%ww/200mg | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1458752014 | Benzocaine + trimethobenzamide hydrochlor 2%ww/200mg suppositoy (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478607016 | Benzocaine + trimethobenzamide hydrochlor 2%ww/200mg suppositoy | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2529264016 | Benzocaine + trimethobenzamide hydrochloride 2%ww/200mg suppository (product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 2532643016 | Benzocaine + trimethobenzamide hydrochloride 2%ww/200mg suppository | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3761973017 | Benzocaine 20 microgram and trimethobenzamide hydrochloride 200 mg rectal suppository | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3761974011 | Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | Product containing benzocaine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | Product containing trimethobenzamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Ethanolamine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Antiallergic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Trimethobenzamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Prokinetic Agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Benzocaine | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | Product containing benzocaine and trimethobenzamide hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Trimethobenzamide hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Substance with histamine receptor antagonist mechanism of action | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has active ingredient | Cardiovascular agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has manufactured dose form | Rectal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | Product containing benzocaine in rectal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | Product containing trimethobenzamide in rectal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has manufactured dose form | Conventional release rectal suppository | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator unit | Suppository | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has unit of presentation | Suppository | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Is a | Product containing only benzocaine and trimethobenzamide in rectal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength denominator unit | Suppository | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has basis of strength substance | Benzocaine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has precise active ingredient | Benzocaine | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has basis of strength substance | Trimethobenzamide hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has presentation strength numerator value | 200 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Has precise active ingredient | Trimethobenzamide hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely benzocaine 20 microgram and trimethobenzamide hydrochloride 200 milligram/1 each conventional release rectal suppository (clinical drug) | Plays role | Antiemetic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR